Azitra, Inc.

Azitra, Inc.

Biotechnology Healthcare Branford, CT, United States AZTR (ASE)

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.

Stock Performance (90 Days)

Data through Dec 23, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has Azitra, Inc. had layoffs?
No layoff events have been recorded for Azitra, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Azitra, Inc. have?
Azitra, Inc. has approximately 12 employees.
What industry is Azitra, Inc. in?
Azitra, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Azitra, Inc. a publicly traded company?
Yes, Azitra, Inc. is publicly traded under the ticker symbol AZTR on the ASE. The company has a market capitalization of approximately $0.00 billion.
Where is Azitra, Inc. headquartered?
Azitra, Inc. is headquartered in Branford, CT, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.